Condition

Anatomic Stage IIIA Breast Cancer AJCC v8 clinical trials and research

• 11Clinical trials
• 4Countries

Newest Anatomic Stage IIIA Breast Cancer AJCC v8 clinical trials

All recruiting trials (11)

• Hormone therapy with ribociclib vs chemotherapy followed by hormone therapy with ribociclib for high-risk stage breast cancer

  This trial tests whether hormone therapy with ribociclib works as well as chemotherapy followed by hormone therapy with ribociclib for patients with high-stage, estrogen receptor-positive, HER2-negative breast cancer at low risk of recurrence.

  Recruiting at 257 sites Phase 3 National Cancer Institute (NCI) · Jonesboro, Arkansas and 257 other locations · NCT07391774

• Darolutamide alone or with standard pre-surgery therapy for stage II–IIIA AR‑positive triple‑negative breast cancer.

  This trial will test whether adding darolutamide to standard pre-surgery chemo‑immunotherapy helps people with stage II–IIIA androgen receptor–positive triple‑negative breast cancer.

  Recruiting Phase 2 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07016399

• Personalized tumor vaccine with checkpoint inhibitors for triple negative breast cancer

  This phase I trial will test whether a personalized tumor membrane vesicle (TMV) vaccine, given alone or with pembrolizumab or ipilimumab, can boost immune response and help control disease in adults with triple negative breast cancer.

  Recruiting at 4 sites Phase 1 Emory University · Atlanta, Georgia and 3 other locations · NCT06324240

• Shorter chemotherapy and immunotherapy for early-stage triple negative breast cancer

  This study is testing whether a shorter treatment plan of chemotherapy and immunotherapy without certain strong drugs can help people with early-stage triple negative breast cancer do better than the usual longer treatment.

  Recruiting at 923 sites Phase 3 SWOG Cancer Research Network · Birmingham, Alabama and 962 other locations · NCT05929768

• Comparing pembrolizumab to observation for early-stage triple-negative breast cancer after chemotherapy

  This study tests whether a drug called pembrolizumab can help prevent the return of early-stage triple-negative breast cancer after chemotherapy, compared to just keeping an eye on patients without extra treatment.

  Recruiting at 797 sites Phase 3 Alliance for Clinical Trials in Oncology · Birmingham, Alabama and 845 other locations · NCT05812807

• Using minoxidil to treat hair loss in breast cancer patients on endocrine therapy

  This study is testing if a hair loss treatment called minoxidil, given either as a foam or a pill, can help women with breast cancer who are losing their hair due to cancer therapy.

  Recruiting Early Phase 1 Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT05417308

• Personalized vaccine combined with pembrolizumab for advanced solid tumors

  This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.

  Recruiting Phase 1/2 Mayo Clinic · Jacksonville, Florida · NCT05269381

• Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors

  This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT05092373

• Exercise intervention to improve cognitive function in breast cancer survivors

  This study tests whether a 6-month aerobic exercise program can help improve memory and attention in post-menopausal breast cancer survivors compared to those who only receive health education.

  Recruiting Mayo Clinic · Phoenix, Arizona · NCT04816006

• Combining Olaparib with Cediranib or AZD6738 for Advanced Breast Cancer with BRCA Mutations

  This study is testing if combining the drugs olaparib with either cediranib or AZD6738 can help women with advanced breast cancer that has BRCA mutations feel better after they’ve already tried other treatments.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT04090567

• A tool to help patients decide on contralateral prophylactic mastectomy for breast cancer

  This study tests if an online tool can help women newly diagnosed with breast cancer make better choices about having a preventive mastectomy on the other breast.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT02918474

Related topics

Quick answers

How many Anatomic Stage IIIA Breast Cancer AJCC v8 clinical trials are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (11 trials), Puerto Rico (3 trials), Mexico (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 2: 2, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →